Panelists:
Anna-Maria Makri-Pistikou, PhD
COO and Co-founder
Nanoworx
Panelist
Anna-Maria Makri-Pistikou, PhD
Anna-Maria earned her PhD in synthetic biology from Eindhoven University of Technology, where she honed her ability to transform complex science into real-world solutions. At Nanoworx, she oversees operations, bridging the gap between scientific discovery and commercial success to deliver cutting-edge nanomedicine solutions for biotech and academic partners.
Stijn Hofstraat, PhD
Senior Scientist
Nanoworx
Panelist
Stijn Hofstraat, PhD
Stijn studied at Eindhoven University of Technology, earning both his bachelor’s and master’s degrees working on liposomes and polymersomes for drug delivery. Stijn remained at Eindhoven for his PhD, where he developed a new class of nanomedicine using apolipoproteins to deliver RNA therapeutics to innate immune cells. At Nanoworx, Stijn enjoys working at the intersection of science and application—making sure promising ideas in the lab can make it out into the world.
Anne de Dreu, PhD
Senior Scientist
Nanoworx
Panelist
Anne de Dreu, PhD
Anne earned her PhD in biomedical engineering from Eindhoven University of Technology, where she developed nanoparticles designed to modulate the immune system—combining insights from nanomedicine, immunology, and protein engineering to explore new therapeutic strategies. As senior scientist at Nanoworx, Anne is involved with both research and production efforts, managing lab-based projects and working closely with clients to bring innovative ideas to life.
- Time:
With countless nanoparticle formulation options to explore, researchers need a way to quickly identify scalable nanomedicine formulations that deliver their payload efficiently and consistently. Traditional approaches are slow, resource-heavy, and often make it hard to see which candidates truly stand out. Using scalable, high-throughput tools from Unchained Labs such as the Sunny Suite, Nanoworx works with scientists to explore the broad design space of nanoparticle optimization, ensuring high precision and minimal human error throughout the formulation process.
In this GEN webinar, our expert speakers will show how Nanoworx combines technical expertise with scalable workflows to support the seamless development of nanomedicines from early discovery and design to large-scale production. During the webinar, you will learn how the company performs nanoparticle library production and screening with Sunscreen; fine-tuning and scaling with Sunshine; sample work-up with Big Tuna and batch production with Sunbather. Key takeaways include:
- integration of scalable manufacturing, precise liquid handling, and advanced analytics in a single pipeline
- lending expertise with infrastructure to support seamless nanomedicine development from concept to lead material production
- minimizing development risks: reducing time to market while ensuring consistent quality
A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists.
Produced with support from:
The post Level Up Nanomedicine Development with High-Throughput Formulation Screening appeared first on GEN – Genetic Engineering and Biotechnology News.
